REGFRONT

Software as a service (SAAS) services featuring software incorporating collaborative tools and artificial intelligence for accessing, compiling, integrating, displaying, storing, sorting and analyzing data in the field of life science research and pharmaceutical drug development; Software as a service (SAAS) services featuring software for regulatory project management, namely, for generating, managing and archiving project requirements, documents, product specifications and proposals for communication with health regulatory agencies, including formal submissions and meetings; Software as a service (SAAS) services featuring regulatory compliance and reporting software; Software as a service (SAAS) services featuring software for research, analysis, visualization, tabulation, standards review, organizing and reporting of information for communication with regulatory agencies; Software as a service (SAAS) services featuring software for drug development strategy; Software as a service (SaaS) services featuring software for drug delivery, clinical trials, drug development, automated drug regulatory processes, and compliance with drug registration; Computer software services for providing aforementioned services using artificial intelligence